Fungus-fighting drug may make mild flu meaner
The findings suggest that patients receiving the antifungal therapy may be functionally immunocompromised and more vulnerable to influenza and other viral infections, the researchers said. "Many critically ill cancer and bone marrow transplant patients are treated with Amphotericin B-based therapies each year," said Abraham Brass of the University of Massachusetts Medical School (UMMS)…